MFS Meridian Funds - Blended Research European Equity Fund W1 EURRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 30-04-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | -5,4 | 28,8 | -8,0 | 14,5 | 5,7 | |
+/-Cat | -4,1 | 5,8 | 5,2 | 0,2 | -0,7 | |
+/-Idx | -2,4 | 3,4 | 1,7 | -1,4 | -1,1 | |
Categorie: Aandelen Europa Large-Cap Gemengd | ||||||
Categorie Benchmark: Morningstar DM Eur TME NR EUR |
Kerngegevens | ||
Koers 03-05-2024 | EUR 22,86 | |
Rendement 1 Dag | 0,00% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Gemengd | |
Vestigingsland | Luxemburg | |
ISIN | LU0944407930 | |
Grootte Fonds (Mil) 03-05-2024 | EUR 8,26 | |
Grootte Fondsklasse (Mil) 03-05-2024 | EUR 0,14 | |
Aankoopkosten (Max) | - | |
Lopende Kosten Factor 15-12-2023 | 0,70% |
Beleggingsdoelstelling: MFS Meridian Funds - Blended Research European Equity Fund W1 EUR |
The Fund’s objective is capital appreciation, measured in Euros. The Fund invests primarily (at least 70%) in European equity securities. Some of the countries in Europe, primarily those in Eastern Europe, are currently considered emerging market economies. The Fund may invest in companies it believes to have above average earnings growth potential compared to other companies (growth companies), in companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. The Fund generally focuses its investments in larger companies, but may invest in companies of any size. The Fund may invest a relatively large percentage of its assets in a small number of countries and/or a particular geographic region. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Jonathan Sage 28-06-2016 | ||
James Fallon 28-06-2016 | ||
Click here to see others | ||
Oprichtingsdatum 19-08-2013 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? MFS Meridian Funds - Blended Research European Equity Fund W1 EUR | 31-03-2024 |
|
|
Top 5 posities | Sector | % |
ASML Holding NV | Technologie | 4,52 |
Nestle SA | Defensieve Consumptiegoederen | 3,18 |
Novo Nordisk A/S Class B | Gezondheidszorg | 2,89 |
Roche Holding AG | Gezondheidszorg | 2,62 |
Novartis AG Registered Shares | Gezondheidszorg | 2,52 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
MFS Meridian Funds - Blended Research European Equity Fund W1 EUR |